Observers have long noted the problem of the revolving door between federal agencies and the nation’s largest corporations. Now, we see the same dynamic recreate itself in the nonprofit sector, threatening the public’s confidence in our sector’s stewardship.
Purdue Pharma ends direct sales calls to doctors for OxyContin, but still faces growing legal pressures. Meanwhile, Purdue’s owners, the philanthropic Sackler family, face their own reckoning, as the drug that brought them billions continues to decimate many US communities.
Drug companies have been fined over excessive promotion of opioids, but their business model has been largely unaffected to date. However, that may be changing as lawsuits filed by states, local governments, and American Indian nations mount and opioid deaths rise.